Financials ContextVision AB

Equities

CONTX

SE0014731154

Advanced Medical Equipment & Technology

Market Closed - Oslo Bors 10:45:00 2024-04-30 am EDT 5-day change 1st Jan Change
5.86 NOK -2.01% Intraday chart for ContextVision AB -4.56% -23.90%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 798.5 1,710 1,274 707.1 595.7 453.4 - -
Enterprise Value (EV) 1 772.1 1,668 1,249 665.1 537.1 380.2 373.8 361.5
P/E ratio 114 x 135 x -175 x 21.6 x 18.2 x 25.4 x 22.4 x 14.6 x
Yield - - - 3.29% - 3.43% 4.28% 5.15%
Capitalization / Revenue 8.83 x 17.6 x 13.6 x 6.11 x 4.47 x 3.36 x 3.22 x 2.96 x
EV / Revenue 8.53 x 17.2 x 13.3 x 5.75 x 4.03 x 2.82 x 2.65 x 2.36 x
EV / EBITDA 28.8 x 64 x 581 x 13.8 x 10.9 x 8.53 x 7.76 x 6.85 x
EV / FCF 395 x 121 x 279 x 32.2 x 13.7 x 25.2 x 16.9 x 11.2 x
FCF Yield 0.25% 0.83% 0.36% 3.11% 7.27% 3.97% 5.92% 8.9%
Price to Book 12.8 x - - - - - - -
Nbr of stocks (in thousands) 76,777 77,368 77,208 77,368 77,368 77,368 - -
Reference price 2 10.40 22.10 16.50 9.140 7.700 5.860 5.860 5.860
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 90.46 96.88 93.85 115.7 133.3 134.8 140.8 152.9
EBITDA 1 26.8 26.04 2.15 48.2 49.28 44.57 48.19 52.82
EBIT 1 19.05 15.91 -8.64 40.39 40.37 22.53 25.35 39.13
Operating Margin 21.06% 16.42% -9.21% 34.91% 30.29% 16.72% 18% 25.59%
Earnings before Tax (EBT) 1 9.266 15.58 -8.778 40.31 41.61 22.13 25.15 39.23
Net income 1 7.021 12.35 -7.311 28.27 33 18.11 20.12 31.19
Net margin 7.76% 12.75% -7.79% 24.44% 24.76% 13.43% 14.29% 20.39%
EPS 2 0.0911 0.1636 -0.0945 0.4223 0.4235 0.2310 0.2620 0.4020
Free Cash Flow 1 1.953 13.83 4.484 20.67 39.07 15.09 22.13 32.19
FCF margin 2.16% 14.28% 4.78% 17.86% 29.31% 11.19% 15.71% 21.05%
FCF Conversion (EBITDA) 7.29% 53.11% 208.58% 42.88% 79.28% 33.86% 45.93% 60.95%
FCF Conversion (Net income) 27.82% 111.98% - 73.09% 118.38% 83.33% 110% 103.23%
Dividend per Share 2 - - - 0.3011 - 0.2010 0.2510 0.3020
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 25.28 26.21 - 30.81 25.51 31.98 33.48 33.51 33.93 33.49 33.2
EBITDA 1 5.537 - 8.636 14.7 12.59 10.82 13.54 15.61 14.6 5.248 12.07
EBIT 1 2.842 -4.758 6.793 12.81 10.63 8.978 11.2 13.41 - 3.2 9.054
Operating Margin 11.24% -18.15% - 41.57% 41.67% 28.08% 33.45% 40.03% - 9.55% 27.27%
Earnings before Tax (EBT) 1 2.806 -4.794 6.738 12.75 10.58 9.253 11.15 13.38 12.24 4.555 6.036
Net income 1 2.228 -4.293 2.786 9.137 8.335 7.247 8.912 10.63 9.748 3.484 5.03
Net margin 8.81% -16.38% - 29.65% 32.68% 22.66% 26.62% 31.72% 28.73% 10.4% 15.15%
EPS 2 - -0.0555 - 0.1181 0.1043 0.0982 0.1137 - 0.1305 0.0403 0.0600
Dividend per Share - - - - - - - - - - -
Announcement Date 10/21/21 2/17/22 4/21/22 8/11/22 10/20/22 2/16/23 4/27/23 8/24/23 10/26/23 2/15/24 -
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 26.4 42 24.8 42 58.6 73.1 79.6 91.8
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 1.95 13.8 4.48 20.7 39.1 15.1 22.1 32.2
ROE (net income / shareholders' equity) 11.9% 16.6% -13% 55.2% 45.3% 32% 32% 33%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 0.8100 - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 21.8 8.7 4.46 4.85 0.82 1.01 1.01 1.01
Capex / Sales 24.08% 8.98% 4.75% 4.19% 0.62% 0.75% 0.71% 0.66%
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1NOK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5.86 NOK
Average target price
6.5 NOK
Spread / Average Target
+10.92%
Consensus
  1. Stock Market
  2. Equities
  3. CONTX Stock
  4. Financials ContextVision AB